share_log

bluebird bio | 144: Notice of proposed sale of securities pursuant to Rule 144

bluebird bio | 144: Notice of proposed sale of securities pursuant to Rule 144

bluebird bio | 144:擬議出售證券
美股SEC公告 ·  2024/10/02 03:16

Moomoo AI 已提取核心訊息

Andrew Obenshain, an officer and director at Bluebird Bio, Inc., is set to sell 34,780 shares of the company's common stock. The transaction is scheduled for 09/30/2024, with the shares valued at an aggregate market value of $18,085.60. These shares were originally acquired on 08/02/2024, as vested restricted stock units under the company's equity plan, and were partly sold to cover withholding taxes. The securities were obtained from the issuer for services rendered. No other sales have been reported by Obenshain in the past three months. The notice for this planned transaction was filed on 10/01/2024, following the adoption of a plan or instruction given on 05/10/2023.
Andrew Obenshain, an officer and director at Bluebird Bio, Inc., is set to sell 34,780 shares of the company's common stock. The transaction is scheduled for 09/30/2024, with the shares valued at an aggregate market value of $18,085.60. These shares were originally acquired on 08/02/2024, as vested restricted stock units under the company's equity plan, and were partly sold to cover withholding taxes. The securities were obtained from the issuer for services rendered. No other sales have been reported by Obenshain in the past three months. The notice for this planned transaction was filed on 10/01/2024, following the adoption of a plan or instruction given on 05/10/2023.
Andrew Obenshain,Blubird Bio,Inc.的一名軍官和董事,計劃出售公司普通股34,780股。交易定於2024年09月30日進行,股票價值18,085.60美元。這些股票最初是在2024年08月02日根據公司的股權計劃作爲歸屬的限制性股份單位獲取的,部分股票被出售以支付預扣稅金。這些證券是從發行人處因提供的服務而獲得的。Obenshain在過去三個月中沒有報告其他銷售。此計劃交易的通知在2024年10月01日提交,這是根據於2023年05月10日製定的計劃或指令。
Andrew Obenshain,Blubird Bio,Inc.的一名軍官和董事,計劃出售公司普通股34,780股。交易定於2024年09月30日進行,股票價值18,085.60美元。這些股票最初是在2024年08月02日根據公司的股權計劃作爲歸屬的限制性股份單位獲取的,部分股票被出售以支付預扣稅金。這些證券是從發行人處因提供的服務而獲得的。Obenshain在過去三個月中沒有報告其他銷售。此計劃交易的通知在2024年10月01日提交,這是根據於2023年05月10日製定的計劃或指令。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息